| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 09/21/2006 | US20060211732 Hydroxamic acid derivatives as antibacterials |
| 09/21/2006 | US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/21/2006 | DE102005011050A1 Verfahren zur Herstellung von 1-Aminopiperidinderivaten A process for the preparation of 1-aminopiperidine derivatives |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2600904A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/20/2006 | EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/20/2006 | EP1701945A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof |
| 09/20/2006 | EP1701695A1 Merocyanine derivatives for cosmetic use |
| 09/20/2006 | CN1835938A Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 09/20/2006 | CN1835913A Propionic acid derivatives useful in the treatment of lipid disorders |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/19/2006 | US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 09/19/2006 | US7109347 Inhibitor is an amino acid linked to a thiazolidine or a pyrrolidine group by a peptide bond, e.g., L-threo-isoleucylpyrrolidine, L-allo-isoleucylthiazolidine, L-allo-isoleucylpyrrolydine, L-glutamoylthiazolidine, L-glutamoylpyrrolidine, L-glutamoythiazolidine, L-glutamoylpyrrolidine and their salts |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 09/14/2006 | WO2006095263A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 09/14/2006 | WO2006094843A1 Piperazine derivatives as glyt1 inhibitors |
| 09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
| 09/14/2006 | WO2006094840A1 Compounds |
| 09/14/2006 | WO2006094648A1 Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
| 09/14/2006 | WO2006094549A1 A PROCESS FOR THE PREPARATION OF AN 11-(4-SUBSTITUTED-I-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE DERIVATIVE |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205726 e.g. 2-(2-{3-acetoxy-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetoxymethyl)-2-phenylmalonic acid diethyl ester; microsomal triglyceride transfer protein inhibitor in small intestine; antihyperlipidemic, antidiabetic agent; arteriosclerosis, coronary artery diseases, obesity |
| 09/14/2006 | US20060205675 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 09/14/2006 | CA2600633A1 Process for the preparation of 1-aminopiperidine derivatives |
| 09/13/2006 | EP1700845A1 Insecticidal anthranilamides |
| 09/13/2006 | EP1700844A1 Phthalic acid diamide derivatives, agricultural and horticultural insecticides and a method for application of the insecticides |
| 09/13/2006 | EP1699770A1 Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833003A Sulfonamide anions as catalysts for nco oligomerization |
| 09/13/2006 | CN1832920A Aryl and heteroaryl compounds, compositions, and methods of use |
| 09/13/2006 | CN1832912A Clear photopolymerizable systems for the preparation of high thickness coatings |
| 09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
| 09/13/2006 | CN1830971A Method for producing marpholine and monoethylamine using by-products N-ethylamine from morpholine prodn. installation as raw material |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105662 Method of producing N-substituted 2,6-dialkylmorpholines |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105541 Naphthyl compounds, intermediates, compositions, and methods of use |
| 09/12/2006 | US7105521 1-(2 chlorophenyl-1-piperazinyl)-2-propanol-3-oxy-(2-methoxy-propenyl)-benzene; alpha 2-adrenergic/5-HT2A antagonist, 5-HT re-uptake inhibition, and anti-oxidant activities |
| 09/12/2006 | US7105520 Alpha 4 integrin antagonists |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006093823A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | WO2006092074A1 Menthane carboxamide derivatives having cooling properties |
| 09/08/2006 | WO2006055542A3 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use |
| 09/08/2006 | CA2599808A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | CA2597415A1 Menthane carboxamide derivatives having cooling properties |
| 09/07/2006 | US20060199848 Ion channel modulating activity II |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | DE102006006123A1 Use of alk-2-en-4-acidamide compounds e.g. as aroma materials, for producing tingling sensation or cooling effect and/or stimulation of saliva in mouth, for mouth hygiene and in oral pharmaceutical preparation |
| 09/07/2006 | DE102005010000A1 Indane Indanes |
| 09/07/2006 | DE102005009136A1 Verbessertes Verfahren zur Herstellung von bifunktionellen Ammoniumnitrilen An improved process for producing bifunctional ammonium nitriles |
| 09/07/2006 | DE102005008412A1 New piperazine salt of omeprazol is proton pump inhibitor useful to prevent/treat e.g. peptic ulcer, gastritis, gastroesophageal reflux, acute stress ulcer or dyspepsia |
| 09/06/2006 | EP1698631A1 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
| 09/06/2006 | CN1829703A (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 09/06/2006 | CN1827733A Organic electroluminescence device |
| 09/06/2006 | CN1827610A Process for preparing 4-acyl substituted-2-methylpiperazines |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 09/05/2006 | US7101894 Administering quinoline derivative for therapy of Cytomegalovirus infections in human pathogen |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101887 Treating neuropsycological diseases; schizophrenia, psychotic depression and mania |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 08/31/2006 | WO2006091160A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 08/31/2006 | WO2006074025B1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/30/2006 | EP1695971A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 08/30/2006 | EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 08/30/2006 | EP1694643A1 Carboxamide derivatives |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694627A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1556365B1 Improvement in the storage stability of photoinitiators |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP0994100B1 3-anilino-2-cycloalkenone derivates |
| 08/30/2006 | CN1824659A Synthesis method of butadiene morpholine |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |